Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Budget calculator numbers can be opaque. Learn what they mean and how to translate them into concrete next steps.
17,878 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
SpaceX moved from private doors to public indices, nudging indirect ownership into millions of portfolios. Learn what...
Nike delivered a quarterly beat that sent its shares higher, but investors kept a close eye on tariffs and future gui...
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
Energy markets swing, yet Enterprise Products Partners has built a resilient income stream through a toll-road model....
A billionaire places a bold personal bet on a private space company. This article breaks down what that move means fo...
When a CEO sells shares, investors watch closely. This piece breaks down Exponent's move by Catherine Corrigan, expla...
SoFi shareholders have faced a tough year, but a pair of upbeat bank results offers a new tailwind. This article brea...
Meta platforms just gave a crucial signal about AI-driven cloud demand. This piece breaks down why Nebius could stand...
When a smart-home name rallies, traders pay attention. This piece breaks down why resideo technologies stock popped o...
Sable Offshore stock tanked over the last year as oil markets swung and investors weighed long-term offshore exposure...
Kazakhstan's central bank is considering a $350 million crypto-related portfolio funded in part by gold reserves. Off...